| Date | Company Name | Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|---|
| May 25, 2022 | Rapt Therapeutics | Post-IPO Equity | — | Biotechnology | Yes |
| Feb 16, 2022 | Star Therapeutics | Series Unknown | — | — | |
| Oct 7, 2021 | Science 37 | Post-IPO Equity | — | Biotechnology | — |
| Sep 9, 2021 | Mammoth Biosciences | Series D | — | Biotechnology | Yes |
| Jul 13, 2021 | Prime Medicine | Series B | — | Biotechnology | — |
| Jun 23, 2021 | Strand Therapeutics | Series A | — | Biotechnology | — |
| Mar 31, 2021 | Entrada Therapeutics | Series B | — | Biotechnology | — |
| Mar 23, 2021 | Absci | Series Unknown | — | Artificial Intelligence | Yes |
| Jan 19, 2021 | Verve Therapeutics | Series B | — | Biotechnology | — |
| Jan 19, 2021 | Beam Therapeutics | Post-IPO Equity | — | Biotechnology | — |
| Dec 23, 2020 | SomaLogic | Series A | — | Biotechnology | — |
| Nov 4, 2020 | Mammoth Biosciences | Series C | — | Biotechnology | Yes |
| Oct 20, 2020 | Absci | Series E | — | Artificial Intelligence | — |
| Aug 20, 2020 | Science 37 | Series Unknown | — | Biotechnology | Yes |
| Jul 9, 2019 | BioNTech | Series B | — | Biopharma | — |
| Mar 6, 2019 | Beam Therapeutics | Series B | — | Biotechnology | — |
| Jan 3, 2019 | Science 37 | Series D | — | Biotechnology | — |
| Jan 4, 2018 | BioNTech | Series A | — | Biopharma | Yes |
| Sep 8, 2017 | Replimune Group | Series B | — | Biotechnology | — |
| Apr 25, 2017 | Science 37 | Series C | — | Biotechnology | — |
| Oct 18, 2016 | Science 37 | Series B | — | Biotechnology | Yes |
| Nov 12, 2014 | Blueprint Medicines | Series C | — | Bioinformatics | — |
| Oct 13, 2014 | Invitae | Series F | — | Biotechnology | — |
| Dec 10, 2013 | Invitae | Series E | — | Biotechnology | — |
| Apr 26, 2011 | Oxford Nanopore Technologies | Series Unknown | — | Biopharma | — |